Selank Anxiolytic Properties refer to the documented effects of the synthetic peptide Selank, a heptapeptide analog of the naturally occurring human immunomodulatory peptide tuftsin, in reducing anxiety and generalized fear states without causing sedation or cognitive impairment. Clinically, these properties are leveraged to improve emotional regulation, enhance stress resilience, and support neuro-chemical balance in individuals experiencing chronic stress or anxiety disorders. It is distinct from conventional anxiolytics due to its unique mechanism of action.
Origin
Selank was developed by the Institute of Molecular Genetics of the Russian Academy of Sciences in the early 2000s, initially based on research into the body’s endogenous regulatory peptides. The term ‘anxiolytic’ is derived from the Greek anxio (anxiety) and lytic (to loosen or dissolve), accurately describing its primary therapeutic function in reducing pathological anxiety.
Mechanism
The anxiolytic mechanism of Selank is multi-faceted and thought to involve the modulation of the GABAergic system and the enhancement of serotonin metabolism. Crucially, it is believed to influence the expression and function of BDNF, promoting neuroplasticity in areas of the brain involved in fear and anxiety processing, such as the hippocampus and amygdala. This leads to a stabilized emotional state and improved adaptive response to stress.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.